The present disclosure relates to a safety sealing mechanism used in conjunction with radiopharmaceutical unit dose containers. In the field of nuclear medicine, radioactive materials (known as radiopharmaceuticals) are used in various applications. Typically, radiopharmaceuticals are delivered to a caregiver from an outside pharmacy “pre-loaded” into a syringe. Due to the radioactive nature of such radiopharmaceuticals, great care must be utilized in handling. It is common industry practice for the outside pharmacy to ship the syringe-loaded radiopharmaceutical (or other unit dose format) in a shielded container, referred to as a “radiopharmaceutical pig”. The radiopharmaceutical pig generally consists of a base and a cover that is threadably attachable to the base. For various reasons, it is important for caregivers and/or pharmacies to quickly recognize when a radiopharmaceutical pig has been opened (i.e., the cover unscrewed from the base). One current approach for providing this tamper evident safety feature is by applying a shrink wrap about the radiopharmaceutical pig. To effectuate disassembly of the cover from the base, the shrink wrap must be removed (or at least torn). While viable, this approach entails added manufacturing/handling costs, and caregivers may experience difficulties in removing and/or disposing of the shrink wrap.
Aspects of the present disclosure relate to a tamper evident seal and method for sealing a radiopharmaceutical container. The seal includes a first band, a second band and a connector assembly adapted to be positioned around the container. First and second arms connect the first band to the second band. The connector assembly includes a connector connecting two ends of the seal together and a breakaway portion provided to separate two ends of the seal so as to provide visual evidence the seal has been broken.
In one embodiment, the first band forms an uninterrupted circle adapted to be positioned around an upper portion of the container and the second band includes the connector assembly and is adapted to be positioned around a lower portion of the container. In a further embodiment, the first arm connects the first band to a first leg of the connector assembly and the second arm connects the first band to a second leg of the connector assembly.
The accompanying drawings are included to provide a further understanding of embodiments and are incorporated in and constitute a part of this specification. The drawings illustrate embodiments and together with the description serve to explain principles of embodiments. Other embodiments and many of the intended advantages of embodiments will be readily appreciated as they become better understood by reference to the following detailed description. The elements of the drawings are not necessarily to scale relative to each other. Like reference numerals designate corresponding similar parts.
In the following Detailed Description, reference is made to the accompanying drawings, which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. In this regard, directional terminology, such as “top,” “bottom,” “front,” “back,” “leading,” “trailing,” etc., is used with reference to the orientation of the Figure(s) being described. Because components of embodiments can be positioned in a number of different orientations, the directional terminology is used for purposes of illustration and is in no way limiting. It is to be understood that other embodiments may be utilized and structural or logical changes may be made without departing from the scope of the present invention. The following detailed description, therefore, is not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims.
It is to be understood that the features of the various exemplary embodiments described herein may be combined with each other, unless specifically noted otherwise.
As further illustrated in
As initially provided, the first ends 30a, 30b are interconnected by the connection tab 28. The first end 30a is connected to a first portion of the tab 28 and spaced apart from the first end 30b. The second ends 32a, 32b are free. In other words, the second ends 32a, 32b can be moved relative to one another, allowing a diameter collectively defined by the legs 26a, 26b to be increased or decreased as desired. In this regard, the first leg 26a forms a male plug 34, and the second leg 26b forms a female receptacle 36 at the corresponding second end 32. The plug 34/receptacle 36 are configured such that the plug 34 can be captured within the receptacle 36, and such that once captured, the plug 34 cannot be removed from the receptacle 36 without destroying the plug 34 (i.e., forming a non-removable connector).
During use, the seal 10 is applied over the radiopharmaceutical pig 12 by sliding the connector assembly 24 and the first band 20 over the tube 14. Due to the extendable nature of the legs 26a, 26b relative to one another at the second ends 32a, 32b, the collective diameter of the legs 26a, 26b can be expanded so as to slide over the flange 16. The first band 20, however, has a diameter less than that of the flange 16, and thus cannot slide beyond the flange 16. Once in the partial assembled position as shown in
To access pig 12, the seal 10 must first be removed; this is accomplished by breaking the connection tab 28 (e.g., the connection tab 28 is twisted relative to the legs 26a, 26b). Once broken, the first ends 30a, 30b can freely be moved relative to one another, allowing a user to displace the legs 26a, 26b to an effective diameter greater than that of the flange 16. As a result, the user can now slide the seal 10 off of the pharmaceutical pig 12. The removed seal 10 will clearly have the “broken” connection tab 28 (e.g., the connection tab 28 will no longer be connected to one or both of the legs 26a, 26b), whereas the second ends 32a, 32b will remain connected to one another. As a result, a visual indication that the pharmaceutical pig has been opened (or at least an attempt was made to open) will be quickly evident.
Although specific embodiments have been illustrated and described herein, it will be appreciated by those of ordinary skill in the art that a variety of alternate and/or equivalent implementations may be substituted for the specific embodiments shown and described without departing from the scope of the present invention. This application is intended to cover any adaptations or variations of the specific embodiments discussed herein. Therefore, it is intended that this invention be limited only by the claims and the equivalents thereof.
Number | Name | Date | Kind |
---|---|---|---|
110421 | Bates | Dec 1870 | A |
402370 | Walch | Apr 1889 | A |
760879 | Kunzman | May 1904 | A |
1278385 | Rickard | Sep 1918 | A |
3339775 | Valentin | Sep 1967 | A |
3379328 | Plion | Apr 1968 | A |
4280258 | Kunze | Jul 1981 | A |
4470173 | Adamson | Sep 1984 | A |
4501049 | Adamson | Feb 1985 | A |
4588218 | Guiler et al. | May 1986 | A |
4993570 | Julian et al. | Feb 1991 | A |
5056837 | Fuehrer | Oct 1991 | A |
5191992 | Darley | Mar 1993 | A |
5348180 | Shepard | Sep 1994 | A |
5350372 | Ikeda et al. | Sep 1994 | A |
5397012 | Tison et al. | Mar 1995 | A |
5429256 | Kestenbaum | Jul 1995 | A |
5462182 | Opresco | Oct 1995 | A |
5519931 | Reich | May 1996 | A |
5524945 | Georgopoulos et al. | Jun 1996 | A |
5526853 | McPhee et al. | Jun 1996 | A |
5853093 | Neiger | Dec 1998 | A |
5865330 | Buono | Feb 1999 | A |
6158153 | Morgan | Dec 2000 | A |
D436706 | Clinton | Jan 2001 | S |
6328356 | Aichmann | Dec 2001 | B1 |
6343819 | Shiozaki | Feb 2002 | B1 |
6449808 | Zappa et al. | Sep 2002 | B1 |
6648313 | Navarro | Nov 2003 | B2 |
6828509 | Ito et al. | Dec 2004 | B2 |
6854210 | Gunderman | Feb 2005 | B2 |
6895712 | Gunderman et al. | May 2005 | B2 |
7052055 | Castro et al. | May 2006 | B1 |
7062820 | Oestreich et al. | Jun 2006 | B1 |
7246830 | Graves et al. | Jul 2007 | B2 |
20020121496 | Thiebault et al. | Sep 2002 | A1 |
20050062608 | Costa | Mar 2005 | A1 |
20060289541 | Boback et al. | Dec 2006 | A1 |
20070120701 | Teller | May 2007 | A1 |
20080028677 | Shelton | Feb 2008 | A1 |
20080289372 | Rendon et al. | Nov 2008 | A1 |
Number | Date | Country | |
---|---|---|---|
20100185170 A1 | Jul 2010 | US |